-
Guidance on amendments to the Food and Drug Regulations for drugs for use in...
A promising COVID-19 drug may be imported into Canada before it receives a Canadian market authorization. This early importation and placement in Canadian facilities is referred... -
Water quality and health videos (Described videos)
Water quality affects everyone. Find out more about water pollution and your health. -
Drug Product Database - All Files
The Drug Product Database (DPD) system captures information on Canadian human, veterinary and disinfectant products approved for use by Health Canada. To facilitate the use of... -
Food Irradiation
This section provides information on food irradiation and its regulation in Canada. -
Federal contaminated site risk assessment in Canada: Guidance on human...
This guidance document was prepared to provide guidance for custodial departments of federal contaminated sites. -
Health Care System Innovation
The Health Care System Innovation (HCSI) component is designed to stimulate health care policy analysis and development, advance strategic thinking and policy options, and... -
Module 4: Health Canada’s review and communication of safety findings
Educational module provides overview of health product vigilance, report management, post-market surveillance activities and Health Canada risk communications. -
Federal actions on opioids to date
In keeping with the Government’s public-health centred approach to substance use and the opioid epidemic, the Minister of Justice introduced Bill-C-22. -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
Guideline Technical Document - Enteric Viruses equation-3 -
Consumer Product Enforcement Summary Report Cyclical Enforcement Project...
The purpose of this Cyclical Enforcement (CE) project was to verify industry's compliance of consumer chemicals with the requirements of the Consumer Chemicals and Containers... -
Guidance Document: Notice of Compliance with Conditions (NOC/c)
This guidance document combines and supercedes the policy and guidance documents for Notices of Compliance with Conditions (NOC/c) dated June 12, 2007. The revisions to this... -
Industry Guide to Vaping Products Subject to the Canada Consumer Product Safety Act
This guide provides information to industry on requirements under the Canada Consumer Product Safety Act (CCPSA) for vaping products that are manufactured, imported, advertised... -
Consumer Product Enforcement Summary Report - Cyclical Enforcement Project...
The purpose of this Cyclical Enforcement (CE) project was to verify industry’s compliance of Halloween costumes and accessories with the requirements of the Textile Flammability... -
Causes of Drug Shortages in Canada
Drug shortages can occur for any number of reasons and can result from problems at any point in the drug supply chain. -
Use ArriveCAN to enter Canada
Use ArriveCAN to provide mandatory travel information before and after your entry into Canada. It only takes minutes to help keep each other safe. -
Good faith clause under Canada's Access to Medicines Regime
The legislation establishing Canada's Access to Medicines Regime contains a "Good Faith Clause" that provides patent holders with the right to challenge a compulsory licence in... -
Qualifying notice: Pemazyre
This Notice of Compliance with Conditions-Qualifying Notice (NOC/c-QN), issued in accordance with the Health Canada Guidance Document: Notice of Compliance with Conditions... -
Notice of modification to lower the maximum levels for lead in concentrated...
Therefore, Health Canada lowered the maximum levels for lead in infant formula, effective July 3, 2020, by modifying Part 2 of the List of Contaminants and Other Adulterating... -
Health Product InfoWatch – November 2021
The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals,... -
Health Product InfoWatch: December 2023
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published in November 2023 by Health Canada.